These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6175560)

  • 21. Immunology of multiple sclerosis.
    Oger J; Roos R; Antel JP
    Neurol Clin; 1983 Aug; 1(3):655-79. PubMed ID: 6209537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cold-reacting lymphocytotoxic antibodies in the serum of patients with multiple sclerosis.
    Mayer M; Opavský J; Bártová A
    Acta Univ Palacki Olomuc Fac Med; 1983; 104():371-8. PubMed ID: 6222623
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
    Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dilutions and specificity analysis of pretransplant sera.
    Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
    Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgM with antiidiotypic activity against anti-HLA antibodies detected in dithiothreitol-treated sera.
    Urlacher A; Pasquali JL; Mayer S; Tongio MM
    Transplant Proc; 1990 Aug; 22(4):1892. PubMed ID: 2389475
    [No Abstract]   [Full Text] [Related]  

  • 28. Simplification of B-cell antisera of the Merrit system with platelets and lymphoblastoid cell lines.
    Naeim F; Gregg B; Gatti RA; Leibold W; Walford RL
    Transplant Proc; 1977 Mar; 9(1):439-44. PubMed ID: 68582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgM anti-IgM cold lymphocytotoxins to B cells.
    Cicciarelli JC; Chia D; Terasaki PI; Barnett EV; Shirahama S
    Transplant Proc; 1979 Dec; 11(4):1950-3. PubMed ID: 316939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organ-specific IgM autoantibodies to liver, heart and brain in man: generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis.
    Daar AS; Fabre JW
    Clin Exp Immunol; 1981 Jul; 45(1):37-47. PubMed ID: 7030539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-HLA specificity determined by serum absorption with antigen-masked lymphocytes.
    Whitacre LR; Nathan P
    Tissue Antigens; 1980 Nov; 16(5):393-8. PubMed ID: 6162240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of HLA antigens on leukaemia cells.
    Mayer S; Tongio MM; Falkenrodt A; Pfeiffer B; Bergerat JP
    J Immunogenet; 1982 Apr; 9(2):111-20. PubMed ID: 6177797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two monoclonal antibodies detecting allotypic determinants of HLA-A.
    Minami S; Ueda R; Shiraki T; Tanimoto M; Namikawa R; Seto M; Nishida K; Tsuge I; Ota K; Takahashi T
    Tissue Antigens; 1983 Oct; 22(4):239-45. PubMed ID: 6196873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulins in healthy controls: HLA-B8 and sex differences.
    Cryan EM; Stevens FM; Skehill R; Bourke M; Grimes H; McCarthy CF
    Tissue Antigens; 1985 Oct; 26(4):254-8. PubMed ID: 3878013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA antigens of platelets. IV. Influence of "private" HLA--B locus specificities on the expression of Bw4 and Bw6 on human platelets.
    Szatkowski NS; Aster RH
    Tissue Antigens; 1980 Apr; 15(4):361-8. PubMed ID: 7466777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test.
    Fuller TC; Phelan D; Gebel HM; Rodey GE
    Transplantation; 1982 Jul; 34(1):24-9. PubMed ID: 6181591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA serological cross-reactivity: HLA-B15 has two public antigens.
    Schwartz BD; Luehrman LK; Lee T; Rodey GE
    Hum Immunol; 1980 Dec; 1(4):331-45. PubMed ID: 6167552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Freeze dried platelets for HLA alloantibodies absorption.
    Prou O; Kaplan C; Muller JY
    Tissue Antigens; 1980 Jul; 16(1):105-7. PubMed ID: 6970426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-C expression on platelets: studies with an HLA-Cw1-specific human monoclonal antibody.
    Datema G; Stein S; Eijsink C; Mulder A; Claas FH; Doxiadis II
    Vox Sang; 2000; 79(2):108-11. PubMed ID: 11054049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HLA--B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1980 Apr; 15(4):389-97. PubMed ID: 7466779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.